Suppliers / Rohto Mentholatum Vietnam

Rohto Mentholatum Vietnam

Vietnam Updated 9 July 2026

Rohto Mentholatum Vietnam is a finished-dose manufacturer based in Vietnam. It appears in 24 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), EDE (AE) and UZPHARM (UZ). Its most recent recorded inspection, by US FDA, closed on 1 November 2019 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
24
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 1 November 2019 VAI US FDA
  • 16 March 2018 VAI US FDA
  • 14 April 2015 VAI US FDA
  • 15 May 2012 OAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
BINH DUONG, United Arab Emirates Not on file
Vietnam, Vietnam 3008808745

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 12 None
EDE (AE) 6 None
UZPHARM (UZ) 3 None
NPRA (MY) 3 None

Questions about Rohto Mentholatum Vietnam

Does Rohto Mentholatum Vietnam hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Rohto Mentholatum Vietnam. It does have 24 filings with 4 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Rohto Mentholatum Vietnam FDA-registered?
One site operated by Rohto Mentholatum Vietnam carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Rohto Mentholatum Vietnam's last inspection go?
The most recent inspection on record closed on 1 November 2019 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file, of which 1 closed as OAI.
Where does Rohto Mentholatum Vietnam manufacture?
2 registered sites are on record, in United Arab Emirates and Vietnam (Binh Duong and Vietnam). Every site is listed on this page with the register it came from.
Where does Rohto Mentholatum Vietnam file?
Filings are on record with DAV (Vietnam), EDE (AE), UZPHARM (UZ) and NPRA (MY), 24 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Rohto Mentholatum Vietnam comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 1 November 2019.

Comparable suppliers

Danapha Pharmaceutical Joint Stock also in Vietnam Fremed Pharmaceutical Joint Stock also in Vietnam Hanoi Cpc1 Pharmaceutical Joint Stock also in Vietnam Imexpharm also in Vietnam Minh also in Vietnam

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability